Analyst Ratings for Supernus Pharmaceuticals (SUPN)
SUPN Rating Summary
SUPN Price Target Summary
- Highest: $16.00 (Lazard Capital)
- Lowest: $6.00 (Citi)
- Average: $11.20
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.20 (+66.9%)
Avg. $ Target:
$11.20 (+66.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2013 | Jefferies » Updated 5/17/2013 |
New Coverage | Buy (N/A) |
9.00 (13.00) |
7.48 | 6.71 | -10.29% | Details |
| 12/5/2012 | Lazard Capital | New Coverage | Buy (N/A) |
16.00 (N/A) |
7.88 | 6.71 | -14.85% | Details |
| 5/29/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
15.00 (N/A) |
5.94 | 6.71 | 12.96% | Details |
| 5/29/2012 | Citi | New Coverage | Neutral (N/A) |
6.00 (N/A) |
5.94 | 6.71 | 12.96% | Details |
| 5/29/2012 | Piper Jaffray | New Coverage | Overweight (N/A) |
10.00 (N/A) |
5.94 | 6.71 | 12.96% | Details |
